Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLA-DMB | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | SAT2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | VIPR1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | RPS4X | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | SLC25A31 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | CRHR1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | URI1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | SMIM6 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | OR52A5 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | SYPL1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |